Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024

Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that it will report its first quarter 2024 financial and operating results on Thursday, May 9, 2024, following the close of the U.S. financial markets. Lineage management will also host a conference call and webcast on Thursday, May 9, 2024, at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time to discuss its first quarter 2024 financial and operating results and to provide a business update.

Interested parties may access the conference call on May 9 th , 2024, by dialing (800) 715-9871 from the U.S. and Canada and should request the "Lineage Cell Therapeutics Call". A live webcast of the conference call will be available online in the Investors section of Lineage's website. A replay of the webcast will be available on Lineage's website for 30 days and a telephone replay will be available through May 15 th , 2024, by dialing (800) 770-2030 from the U.S. and Canada and entering conference ID number 1330332.

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel or "off-the-shelf," cell therapies to address unmet medical needs. Lineage's programs are based on its proprietary cell-based technology platform and associated development and manufacturing capabilities. From this platform, Lineage designs, develops, manufactures, and tests specialized human cells with anatomical and physiological functions similar or identical to cells found naturally in the human body. These cells are created by applying directed differentiation protocols to established, well-characterized, and self-renewing pluripotent cell lines. These protocols generate cells with characteristics associated with specific and desired developmental lineages. Cells derived from such lineages are transplanted into patients in an effort to replace or support cells that are absent or dysfunctional due to degenerative disease, aging, or traumatic injury, and to restore or augment the patient's functional activity. Lineage's neuroscience focused pipeline currently includes: (i) OpRegen, a retinal pigment epithelial cell therapy in Phase 2a development under a worldwide collaboration with Roche and Genentech, a member of the Roche Group, for the treatment of geographic atrophy secondary to age-related macular degeneration; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of spinal cord injuries; (iii) ANP1, an auditory neuronal progenitor cell therapy for the potential treatment of auditory neuropathy; (iv) PNC1, a photoreceptor neural cell therapy for the potential treatment of vision loss due to photoreceptor dysfunction or damage; and (v) RND1, a novel hypoimmune induced pluripotent stem cell line being developed in collaboration with Eterna Therapeutics Inc. For more information, please visit www.lineagecell.com or follow the company on X/Twitter @LineageCell .

Lineage Cell Therapeutics, Inc. IR
Ioana C. Hone
( ir@lineagecell.com )
(442) 287-8963

LifeSci Advisors
Daniel Ferry
( daniel@lifesciadvisors.com )
(617) 430-7576

Russo Partners – Media Relations
Nic Johnson or David Schull
( Nic.johnson@russopartnersllc.com )
( David.schull@russopartnersllc.com )
(212) 845-4242

News Provided by Business Wire via QuoteMedia

LCTX:US
The Conversation (0)
Metalsource Mining Receives $1.38 Million from Eric Sprott Warrant Exercise as Silver Hill Gold-Silver Exploration Advances

Metalsource Mining Receives $1.38 Million from Eric Sprott Warrant Exercise as Silver Hill Gold-Silver Exploration Advances

Eric Sprott now holds approximately 19.9% of outstanding shares, as proceeds strengthen Metalsource's treasury to advance aggressive expansion drilling and larger stepouts investigating the potential scale of the Silver Hill polymetallic system in North Carolina.Metalsource Mining Inc. (CSE:... Keep Reading...
America May Be Sitting on a Gold and Silver Fortune Hiding in Plain Sight

America May Be Sitting on a Gold and Silver Fortune Hiding in Plain Sight

MiningNewsWire Editorial Coverage: With U.S. debt climbing above 100% of GDP while central banks are still accumulating gold, investors are once again seeking safety in silver and gold. Zinc, lead, copper and silver, meanwhile, all now appear on the 2025 List of Critical Minerals published by... Keep Reading...
Eric Sprott Announces Changes to His Holdings in Metalsource Mining Inc.

Eric Sprott Announces Changes to His Holdings in Metalsource Mining Inc.

Eric Sprott announces that on November 17, 2026, 2176423 Ontario Ltd. (a corporation he beneficially owns) exercised 3,750,000 common share purchase warrants (Warrants) of Metalsource Mining Inc., at $0.30 per common share (Share) and 637,158 Warrants at $0.40 per Share for aggregate... Keep Reading...
Noble Engages Stephen Balch As Strategic Advisor

Noble Engages Stephen Balch As Strategic Advisor

(TheNewswire) Toronto, Ontario November 18, 2026 TheNewswire - Noble Mineral Exploration Inc. ("Noble" or the "Company") (TSX-V:NOB, FRANKFURT: NB7, OTCQB:NLPXF) is pleased to announce that it is engaging Stephen Balch, through his consulting company, as a Strategic Advisor. "We have had a long... Keep Reading...
Renforth Completes Updated Mineral Resource Estimate On Wholly Owned Parbec Gold Deposit In Malartic, Quebec

Renforth Completes Updated Mineral Resource Estimate On Wholly Owned Parbec Gold Deposit In Malartic, Quebec

(TheNewswire) TORONTO, Ontario — November 18, 2026 TheNewswire — Renforth Resources Inc. (CSE: RFR,OTC:RFHRF | OTC: RFHRF | FSE: 9RR) ("Renforth" or the "Company") is pleased to advise shareholders that P&E Mining Consultants Inc. ("P&E") have completed an updated Mineral Resource Estimate... Keep Reading...
Getty Copper Receives Dot Property Drill Permit and Initiates Geophysical Survey

Getty Copper Receives Dot Property Drill Permit and Initiates Geophysical Survey

HighlightsDrill permit received for the Dot PropertyInduced polarization (IP) geophysical survey commenced1.2 km long copper trend is open for expansion under coverHistorical drill intercepts include 76 m of 0.91% Cu at the North Zone and 101 m of 0.55% Cu at the South ZonePlanning underway for... Keep Reading...

Interactive Chart

Latest Press Releases

Related News